Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.
Journal: The Lancet. Haematology
Published: November 17, 2025
Genetic mutations in lymphocytic variant of hypereosinophilic syndrome: study of five siblings.
Journal: Frontiers in medicine
Published: August 04, 2025
A Diverse Spectrum of Immune Complex- and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell Lymphoma.
Journal: Kidney international reports
Published: December 06, 2021
Emerging new cell therapies/immune therapies in B-cell non-Hodgkin's lymphoma.
Journal: Current problems in cancer
Published: September 09, 2021
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies.
Journal: Leukemia & lymphoma
Published: July 16, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026